Cardiovascular — RIAS Study

The Ramipril in Aortic Stenosis (RIAS) trial started in October 2008 and was a randomised controlled clinical drug trial involving patients with aortic stenosis (narrowing of the aortic valve) at the John Radcliffe Hospital in Oxford. It was supported by the Oxford Biomedical Research Centre, Oxford Radcliffe NHS Trust and Heart Research UK.

file iconDownload the RIAS Final Report (Word file).